TransMedics to Report Third Quarter 2019 Financial Results on November 6, 2019
October 16, 2019 16:05 ET
|
TransMedics
ANDOVER, Mass., Oct. 16, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference
August 26, 2019 16:05 ET
|
TransMedics
ANDOVER, Mass., Aug. 26, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Reports Second Quarter 2019 Financial Results
August 07, 2019 16:05 ET
|
TransMedics
ANDOVER, Mass., Aug. 07, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS™)
July 30, 2019 08:30 ET
|
TransMedics
ANDOVER, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference
July 25, 2019 16:05 ET
|
TransMedics
ANDOVER, Mass., July 25, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019
July 17, 2019 16:05 ET
|
TransMedics
ANDOVER, Mass., July 17, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Reports First Quarter 2019 Financial Results
June 11, 2019 16:05 ET
|
Transmedics
ANDOVER, Mass., June 11, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage
June 03, 2019 08:00 ET
|
Transmedics
ANDOVER, Mass., June 03, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics to Report First Quarter 2019 Financial Results on June 11, 2019
May 30, 2019 16:05 ET
|
Transmedics
ANDOVER, Mass., May 30, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...
TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
May 06, 2019 16:15 ET
|
Transmedics
ANDOVER, Mass., May 06, 2019 (GLOBE NEWSWIRE) -- TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with...